Search Results - Kinik, Gülsüm

  • Showing 1 - 5 results of 5
Refine Results
  1. 1
    Real Competitors to Ruby: The Triel Oxonitridoborates AlB4O6N, Al0.97Cr0.03B4O6N, and Al0.83Cr0.17B4O6N

    Real Competitors to Ruby: The Triel Oxonitridoborates AlB4O6N, Al0.97Cr0.03B4O6N, and Al0.83Cr0.17B4O6N by Widmann, Ingo, Kinik, Gülsüm, Jähnig, Maximilian, Glaum, Robert, Schwarz, Marcus, Wüstefeld, Christina, Johrendt, Dirk, Tribus, Martina, Hejny, Clivia, Bayarjargal, Lkhamsuren, Dubrovinsky, Leonid, Heymann, Gunter, Suta, Markus, Huppertz, Hubert

    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Real Competitors to Ruby: The Triel Oxonitridoborates AlB4O6N, Al0.97Cr0.03B4O6N, and Al0.83Cr0.17B4O6N (Adv. Funct. Mater. 28/2024)

    Real Competitors to Ruby: The Triel Oxonitridoborates AlB4O6N, Al0.97Cr0.03B4O6N, and Al0.83Cr0.17B4O6N (Adv. Funct. Mater. 28/2024) by Widmann, Ingo, Kinik, Gülsüm, Jähnig, Maximilian, Glaum, Robert, Schwarz, Marcus, Wüstefeld, Christina, Johrendt, Dirk, Tribus, Martina, Hejny, Clivia, Bayarjargal, Lkhamsuren, Dubrovinsky, Leonid, Heymann, Gunter, Suta, Markus, Huppertz, Hubert

    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Real Competitors to Ruby: The Triel Oxonitridoborates AlB 4 O 6 N, Al 0.97 Cr 0.03 B 4 O 6 N, and Al 0.83 Cr 0.17 B 4 O 6 N (Adv. Funct. Mater. 28/2024)

    Real Competitors to Ruby: The Triel Oxonitridoborates AlB 4 O 6 N, Al 0.97 Cr 0.03 B 4 O 6 N, and Al 0.83 Cr 0.17 B 4 O 6 N (Adv. Funct. Mater. 28/2024) by Widmann, Ingo, Kinik, Gülsüm, Jähnig, Maximilian, Glaum, Robert, Schwarz, Marcus, Wüstefeld, Christina, Johrendt, Dirk, Tribus, Martina, Hejny, Clivia, Bayarjargal, Lkhamsuren, Dubrovinsky, Leonid, Heymann, Gunter, Suta, Markus, Huppertz, Hubert

    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Real Competitors to Ruby: The Triel Oxonitridoborates AlB 4 O 6 N, Al 0.97 Cr 0.03 B 4 O 6 N, and Al 0.83 Cr 0.17 B 4 O 6 N

    Real Competitors to Ruby: The Triel Oxonitridoborates AlB 4 O 6 N, Al 0.97 Cr 0.03 B 4 O 6 N, and Al 0.83 Cr 0.17 B 4 O 6 N by Widmann, Ingo, Kinik, Gülsüm, Jähnig, Maximilian, Glaum, Robert, Schwarz, Marcus, Wüstefeld, Christina, Johrendt, Dirk, Tribus, Martina, Hejny, Clivia, Bayarjargal, Lkhamsuren, Dubrovinsky, Leonid, Heymann, Gunter, Suta, Markus, Huppertz, Hubert

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  5. 5
    Adherence to guideline-directed medical and device Therapy in outpAtients with heart failure with reduced ejection fraction: The ATA study

    Adherence to guideline-directed medical and device Therapy in outpAtients with heart failure with reduced ejection fraction: The ATA study by Kocabaş, Umut, Kıvrak, Tarık, Yılmaz Öztekin, Gülsüm Meral, Tanık, Veysel Ozan, Özdemir, Ibrahim Halil, Kaya, Ersin, Yüce, Elif Ilkay, Avcı Demir, Fulya, Doğduş, Mustafa, Altınsoy, Meltem, Üstündağ, Songül, Özyurtlu, Ferhat, Karagöz, Uğur, Karakuş, Alper, Urgun, Örsan Deniz, Sinan, Ümit Yaşar, Mutlu, Inan, Şen, Taner, Astarcıoğlu, Mehmet Ali, Kınık, Mustafa, Tok, Özge Özden, Uygur, Begüm, Yeni, Mehtap, Alan, Bahadır, Dalgıç, Onur, Sarıtürk, Çağla, Altay, Hakan, Pehlivanoğlu, Seçkin

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: